Dishman Pharmaceuticals & Chemicals Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Get Dishman Pharmaceuticals & Chemicals Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
DISHMAN PHAR

Click to see a quick summary and important updates about this stock!Dismiss

Dishman Pharmaceuticals & Chemicals Ltd.

BSE: 532526, NSE: DISHMAN

  • Market Capitalisation info

    ₹4,859 Cr


  • 12 Month Earnings info

    ₹161 Cr

  • Price to Earnings info

    30.15

₹301.20

As on 29-May-2017 IST

up-down-arrow7.952.71%

  • Prev Close info

    293.25

  • Day's Openinfo

    288.20

  • Today's Highinfo

    304.20

  • Today's Lowinfo

    278.00

  • Today's Volumeinfo

    16,15,604

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Dishman Pharma & Chem
39.19 -2.98 33.07 96.54 89.48 62.42 9.51
S&P BSE Sensex*
-0.05 -1.73 9.58 -2.55 15.62 13.01 11.89
S&P BSE Healthcare#
-9.36 4.21 9.03 -10.54 24.62 11.39 12.33
As on 29-May-2017  |  *As on 06-Oct-2022  |  #As on 06-Oct-2022
2016
2015
2014
Dishman Pharma & Chem
28.26 147.63 30.30
S&P BSE Sensex
1.95 -5.03 29.89
S&P BSE Healthcare
-12.88 15.06 47.43

Valuation

Stock
Peer Median
Please wait...

Growth & Efficiency

Stock
Peer Median
Please wait...

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        News & Analysis

        No Review & Analysis are available.

        Other Details

        Incorporated

        1983

        Chairman

        Janmejay R Vyas

        Managing Director

        Arpit J Vyas

        Group

        Dishman Pharma

        Headquarters

        Ahmedabad, Gujarat
        Edit edit
        Please wait...
        Please wait...
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          ₹4,858.77 Cr

        • Revenue (TTM) info

          ₹1,672.48 Cr

        • Earnings (TTM) info

          ₹161.17 Cr

        • Cash info

          ₹87.39 Cr

        • Total Debt info

          ₹942.81 Cr

        • Promoters' ownership info

          61.40%

        • Liquidity info

        • 52 Week range info

          ₹-- - --

        • Face value info

          ₹2.00

        • Shares outstanding info

          16,13,94,272

        • 10 Years Aggregate:

          CFO: ₹1,921.71 Cr

          EBITDA: ₹2,503.24 Cr

          Net Profit: ₹1,115.59 Cr

        About The Company

        • Business

          Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

        • Incorporated

          1983

        • Chairman

          Janmejay R Vyas

        • Managing Director

          Arpit J Vyas

        • Group

          Dishman Pharma

        • Listing info

          BSE: 532526, NSE: DISHMAN

        • Country

          India

        • Headquarters info

          Ahmedabad, Gujarat

        • Website info

          www.dishmangroup.com